LC-HRMS based plasma metabolomics analysis for biomarker discovery of neuroblastoma: 3-O-methyldopa is a new biomarker of poor prognosis of metastatic disease
Ontology highlight
ABSTRACT: In this paper we show for the first time a metabolomic-based biomarker discovery using HRMS applied to plasma of NB patients and its validation on a second independent cohort of patients using a different analytical method.
ORGANISM(S): Human Homo Sapiens
TISSUE(S): Blood
DISEASE(S): Cancer
SUBMITTER: Chiara Lavarello
PROVIDER: ST002238 | MetabolomicsWorkbench | Fri Oct 15 00:00:00 BST 2021
REPOSITORIES: MetabolomicsWorkbench
ACCESS DATA